相关实验视频

Updated: Jan 15, 2026

A Simple and Rapid Protocol to Non-enzymatically Dissociate Fresh Human Tissues for the Analysis of Infiltrating Lymphocytes

A Simple and Rapid Protocol to Non-enzymatically Dissociate Fresh Human Tissues for the Analysis of Infiltrating Lymphocytes

Published on: December 6, 2014

在瘤透的B淋巴细胞方面的进展

Yule Zhang¹, Ming Huang¹, Jinxiu Chen¹

¹College of Basic Medical Science, China Three Gorges University, China.

Central-European journal of immunology

|October 13, 2025

概括

瘤透B淋巴细胞 (TIL-B) 在癌症治疗中至关重要,影响免疫治疗的结果,并提供新的治疗点. 了解它们的不同作用是推进癌症免疫治疗策略的关键.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症研究癌症研究

背景情况:

通过T细胞介导的免疫力主导着瘤免疫疗法研究,往往忽视了B细胞的贡献.
新出现的证据强调了瘤透B淋巴细胞 (TIL-B) 在癌症治疗结果和预后方面的重要作用.
TIL-B影响标准治疗和免疫检查点抑制,表明新的免疫治疗策略的潜力.

研究的目的:

审查目前对TIL-B在瘤免疫治疗中的理解.
阐明TIL-B在癌症进展和治疗反应中的多方面的作用.
为开发基于TIL-B的治疗方法提供见解.

主要方法:

文献综述和对TIL-B.当前研究的综合.
分析TIL-B异质性及其功能影响 (抗瘤与前瘤).
探索瘤微环境中的TIL-B相互作用.

主要成果:

TIL-B显著影响治疗结果和患者预后.
TIL-B 种群表现出异质性,导致抗瘤和前瘤功能.
了解TIL-B对于优化当前免疫疗法和开发新的免疫疗法至关重要.

结论:

在瘤免疫疗法中,TIL-B是关键参与者,影响治疗疗效和患者的治疗结果.
TIL-B的各种功能需要进一步的研究,以利用其作为治疗点的潜力.
对TIL-B的全面知识对于推动癌症免疫疗法发展至关重要.

关键词:

临床意义临床意义免疫疗法免疫疗法预后预后预后三级淋巴体结构的第三级淋巴体结构入瘤的B型淋巴细胞

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.